U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech’s COVID-19 vaccine for children aged 5 to 11 as soon as May 17, the New York Times reported on May 16, citing people familiar with the matter.
U.S. will share COVID-19 vaccine technology, Biden tells global summit
Antivirals, BNT162b2 (Pfizer and BioNTech), Congress, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 Vaccines, Janssen COVID-19 Vaccine (J&J), Joe Biden, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemic Preparedness, Pandemics, Summits, Therapeutics, U.S. government, United States, Vaxzevria (previously COVID-19 Vaccine AstraZeneca), WHO, World Bank, World Health OrganizationThe United States will share technologies used to make COVID-19 vaccines through the World Health Organization and is working to expand rapid testing and antiviral treatments for hard-to-reach populations, President Joe Biden said on May 12.
Pfizer Inc. said on May 10 the company will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co., making a big bet on its ability to boost sales of the top-selling pill in a new class of migraine drugs.
Texas doctor calls U.S. COVID deaths nearing 1 million ‘mindblowing’
“Long-Haul” COVID-19, Asymptomatic Patients, BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Restrictions, Coronavirus surge, Coronavirus Vaccines, COVID guidelines, COVID-19 anti-vaxxers, Covid-19 asymptomatic infections, COVID-19 cases, COVID-19 Deaths, Covid-19 fatality rate, COVID-19 inoculations, COVID-19 misinformation, COVID-19 Prevention Measures, COVID-19 protocols, COVID-19 recommendations, COVID-19 risk, COVID-19 Severe Complications, COVID-19 Vaccines, Deaths, Janssen COVID-19 Vaccine (J&J), Mask-wearing, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemics, Therapeutics, Vaccines, Vaxzevria (previously COVID-19 Vaccine AstraZeneca)In the early days of the COVID-19 pandemic, pulmonologist Joseph Varon offered an opinion that made headlines around the world and went viral on social media. Varon was fighting two wars, he said: one against COVID and one against stupidity.
BioNTech continues to build on the success of the company’s mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline to include additional infectious diseases and oncology with a first-in-class CAR-T program in solid tumors.
BioNTech’s first-quarter 2022 sales and earnings more than tripled due to demand for the COVID-19 vaccine the company developed with Pfizer, but the German biotech firm is still forecasting a full-year decline in vaccine sales.
COVID vaccine makers shift focus to boosters
AstraZeneca, Biopharma Companies, BNT162b2 (Pfizer and BioNTech), Coronavirus Vaccines, COVID vaccine mandates, COVID-19 booster shots, COVID-19 shots, COVID-19 Vaccines, CureVac, GlaxoSmithKline, Janssen, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Mixing & Matching Covid-19 Vaccines, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Novavax, R&D, Therapeutics, Vaccines, Vaxzevria (previously COVID-19 Vaccine AstraZeneca)COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as they could over the last 18 months.
Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from variants
AstraZeneca, BNT162b2 (Pfizer and BioNTech), Body Mass Index (BMI), CoronaVac (Sinovac Biotech), COVID-19 immunity, COVID-19 Studies, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Hospitalized COVID-19 Patients, Immune System, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Medical Journals, Messenger RNA (mRNA) Vaccines, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Nature, Nature Communications, Obesity, Omicron (B.1.1.529) (South Africa), R&D, SARS-CoV-2 virus, Sinovac, South Africa, TurkeySevere obesity may weaken the effectiveness of COVID-19 vaccines in those who have never been infected with the coronavirus, according to a small Turkish study. Additionally, South African researchers have found infection with the Omicron variant of the coronavirus can significantly improve the immune system’s ability to protect against other variants, but only in people who have been vaccinated.
COVID worsens asthma in children; booster after infection not as beneficial vs Omicron
Asthma, BNT162b2 (Pfizer and BioNTech), Children, COVID-19 booster shots, COVID-19 Studies, COVID-19 Vaccines, Doctors, Journal of Allergy and Clinical Immunology: In Practice, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), Polymerase Chain Reaction (PCR), R&DAsthma in children may worsen after an infection with the coronavirus, doctors warn. Additionally, among people who were previously infected with the coronavirus, a third dose of an mRNA vaccine from Pfizer/BioNTech or Moderna may not boost their protection against the Omicron variant of the virus, according to new data.
Pfizer Inc. maintained sales forecasts for the company’s pandemic products on May 3 after a series of hikes to revenue projections for its COVID-19 vaccine in 2021, in a sign that dizzying growth has slowed.